Allogene Therapeutics ALLO Q1 2025 earnings
Reported May 13, 2025 · After market close
Revenue estimate$1.7K
EPS estimate-$0.28
Next report
Aug 12, 2026 (in a month)Revenue estimate$2.2K
EPS estimate-$0.16
Financials
Q1 2025Valuation & ratios
Versus estimates
Ask the moment Allogene Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Allogene Therapeutics report Q1 2025 earnings?
- Allogene Therapeutics (ALLO) reported Q1 2025 earnings on May 13, 2025 after market close.
- What were Allogene Therapeutics's Q1 2025 revenue and EPS?
- Allogene Therapeutics reported revenue of - and diluted EPS of $-0.28 for Q1 2025.
- Did Allogene Therapeutics beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $1.7K by $1.7K. EPS beat the consensus estimate of $-0.28 by $0.00.
- How did Allogene Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 100.0% from $22.0K a year earlier and diluted EPS grew 26.3% from $-0.38.
- Where can I find Allogene Therapeutics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001737287-25-000064) directly on SEC EDGAR. The filing index links above go to sec.gov.